Novartis Head Of Pharma Development James Shannon: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Recent deals with Chiron, Human Genome Sciences and NeuTec Pharma highlight Novartis’ strategic priorities.